Chapter/Section Purchase

Leave This Empty:

Global Human Milk Oligosaccharides (HMO) Market Insights and Forecast to 2028

Choose Chapter/Section to Purchase

List of Chapters/Sections(Table Of Content)
1 Study Coverage
1.1 Human Milk Oligosaccharides (HMO) Product Introduction
1.2 Market by Type
1.2.1 Global Human Milk Oligosaccharides (HMO) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 2'-FL & 3-FL
1.2.3 Sialyllactose
1.2.4 LNT & LNnT
1.3 Market by Application
1.3.1 Global Human Milk Oligosaccharides (HMO) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Infant Formula
1.3.3 Functional Food & Beverages
1.3.4 Food/Medical Supplements
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Human Milk Oligosaccharides (HMO) Sales Estimates and Forecasts 2017-2028
2.2 Global Human Milk Oligosaccharides (HMO) Revenue Estimates and Forecasts 2017-2028
2.3 Global Human Milk Oligosaccharides (HMO) Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Human Milk Oligosaccharides (HMO) Sales by Region
2.4.1 Global Human Milk Oligosaccharides (HMO) Sales by Region (2017-2022)
2.4.2 Global Sales Human Milk Oligosaccharides (HMO) by Region (2023-2028)
2.5 Global Human Milk Oligosaccharides (HMO) Revenue by Region
2.5.1 Global Human Milk Oligosaccharides (HMO) Revenue by Region (2017-2022)
2.5.2 Global Human Milk Oligosaccharides (HMO) Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Human Milk Oligosaccharides (HMO) Sales by Manufacturers
3.1.1 Global Top Human Milk Oligosaccharides (HMO) Manufacturers by Sales (2017-2022)
3.1.2 Global Human Milk Oligosaccharides (HMO) Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Human Milk Oligosaccharides (HMO) in 2021
3.2 Global Human Milk Oligosaccharides (HMO) Revenue by Manufacturers
3.2.1 Global Human Milk Oligosaccharides (HMO) Revenue by Manufacturers (2017-2022)
3.2.2 Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Human Milk Oligosaccharides (HMO) Revenue in 2021
3.3 Global Human Milk Oligosaccharides (HMO) Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Human Milk Oligosaccharides (HMO) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Human Milk Oligosaccharides (HMO) Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Human Milk Oligosaccharides (HMO) Sales by Type
4.1.1 Global Human Milk Oligosaccharides (HMO) Historical Sales by Type (2017-2022)
4.1.2 Global Human Milk Oligosaccharides (HMO) Forecasted Sales by Type (2023-2028)
4.1.3 Global Human Milk Oligosaccharides (HMO) Sales Market Share by Type (2017-2028)
4.2 Global Human Milk Oligosaccharides (HMO) Revenue by Type
4.2.1 Global Human Milk Oligosaccharides (HMO) Historical Revenue by Type (2017-2022)
4.2.2 Global Human Milk Oligosaccharides (HMO) Forecasted Revenue by Type (2023-2028)
4.2.3 Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Type (2017-2028)
4.3 Global Human Milk Oligosaccharides (HMO) Price by Type
4.3.1 Global Human Milk Oligosaccharides (HMO) Price by Type (2017-2022)
4.3.2 Global Human Milk Oligosaccharides (HMO) Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Human Milk Oligosaccharides (HMO) Sales by Application
5.1.1 Global Human Milk Oligosaccharides (HMO) Historical Sales by Application (2017-2022)
5.1.2 Global Human Milk Oligosaccharides (HMO) Forecasted Sales by Application (2023-2028)
5.1.3 Global Human Milk Oligosaccharides (HMO) Sales Market Share by Application (2017-2028)
5.2 Global Human Milk Oligosaccharides (HMO) Revenue by Application
5.2.1 Global Human Milk Oligosaccharides (HMO) Historical Revenue by Application (2017-2022)
5.2.2 Global Human Milk Oligosaccharides (HMO) Forecasted Revenue by Application (2023-2028)
5.2.3 Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Application (2017-2028)
5.3 Global Human Milk Oligosaccharides (HMO) Price by Application
5.3.1 Global Human Milk Oligosaccharides (HMO) Price by Application (2017-2022)
5.3.2 Global Human Milk Oligosaccharides (HMO) Price Forecast by Application (2023-2028)
6 North America
6.1 North America Human Milk Oligosaccharides (HMO) Market Size by Type
6.1.1 North America Human Milk Oligosaccharides (HMO) Sales by Type (2017-2028)
6.1.2 North America Human Milk Oligosaccharides (HMO) Revenue by Type (2017-2028)
6.2 North America Human Milk Oligosaccharides (HMO) Market Size by Application
6.2.1 North America Human Milk Oligosaccharides (HMO) Sales by Application (2017-2028)
6.2.2 North America Human Milk Oligosaccharides (HMO) Revenue by Application (2017-2028)
6.3 North America Human Milk Oligosaccharides (HMO) Market Size by Country
6.3.1 North America Human Milk Oligosaccharides (HMO) Sales by Country (2017-2028)
6.3.2 North America Human Milk Oligosaccharides (HMO) Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Human Milk Oligosaccharides (HMO) Market Size by Type
7.1.1 Europe Human Milk Oligosaccharides (HMO) Sales by Type (2017-2028)
7.1.2 Europe Human Milk Oligosaccharides (HMO) Revenue by Type (2017-2028)
7.2 Europe Human Milk Oligosaccharides (HMO) Market Size by Application
7.2.1 Europe Human Milk Oligosaccharides (HMO) Sales by Application (2017-2028)
7.2.2 Europe Human Milk Oligosaccharides (HMO) Revenue by Application (2017-2028)
7.3 Europe Human Milk Oligosaccharides (HMO) Market Size by Country
7.3.1 Europe Human Milk Oligosaccharides (HMO) Sales by Country (2017-2028)
7.3.2 Europe Human Milk Oligosaccharides (HMO) Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Human Milk Oligosaccharides (HMO) Market Size by Type
8.1.1 Asia Pacific Human Milk Oligosaccharides (HMO) Sales by Type (2017-2028)
8.1.2 Asia Pacific Human Milk Oligosaccharides (HMO) Revenue by Type (2017-2028)
8.2 Asia Pacific Human Milk Oligosaccharides (HMO) Market Size by Application
8.2.1 Asia Pacific Human Milk Oligosaccharides (HMO) Sales by Application (2017-2028)
8.2.2 Asia Pacific Human Milk Oligosaccharides (HMO) Revenue by Application (2017-2028)
8.3 Asia Pacific Human Milk Oligosaccharides (HMO) Market Size by Region
8.3.1 Asia Pacific Human Milk Oligosaccharides (HMO) Sales by Region (2017-2028)
8.3.2 Asia Pacific Human Milk Oligosaccharides (HMO) Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Human Milk Oligosaccharides (HMO) Market Size by Type
9.1.1 Latin America Human Milk Oligosaccharides (HMO) Sales by Type (2017-2028)
9.1.2 Latin America Human Milk Oligosaccharides (HMO) Revenue by Type (2017-2028)
9.2 Latin America Human Milk Oligosaccharides (HMO) Market Size by Application
9.2.1 Latin America Human Milk Oligosaccharides (HMO) Sales by Application (2017-2028)
9.2.2 Latin America Human Milk Oligosaccharides (HMO) Revenue by Application (2017-2028)
9.3 Latin America Human Milk Oligosaccharides (HMO) Market Size by Country
9.3.1 Latin America Human Milk Oligosaccharides (HMO) Sales by Country (2017-2028)
9.3.2 Latin America Human Milk Oligosaccharides (HMO) Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Human Milk Oligosaccharides (HMO) Market Size by Type
10.1.1 Middle East and Africa Human Milk Oligosaccharides (HMO) Sales by Type (2017-2028)
10.1.2 Middle East and Africa Human Milk Oligosaccharides (HMO) Revenue by Type (2017-2028)
10.2 Middle East and Africa Human Milk Oligosaccharides (HMO) Market Size by Application
10.2.1 Middle East and Africa Human Milk Oligosaccharides (HMO) Sales by Application (2017-2028)
10.2.2 Middle East and Africa Human Milk Oligosaccharides (HMO) Revenue by Application (2017-2028)
10.3 Middle East and Africa Human Milk Oligosaccharides (HMO) Market Size by Country
10.3.1 Middle East and Africa Human Milk Oligosaccharides (HMO) Sales by Country (2017-2028)
10.3.2 Middle East and Africa Human Milk Oligosaccharides (HMO) Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Abbott
11.1.1 Abbott Corporation Information
11.1.2 Abbott Overview
11.1.3 Abbott Human Milk Oligosaccharides (HMO) Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Abbott Human Milk Oligosaccharides (HMO) Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Abbott Recent Developments
11.2 Inbiose
11.2.1 Inbiose Corporation Information
11.2.2 Inbiose Overview
11.2.3 Inbiose Human Milk Oligosaccharides (HMO) Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Inbiose Human Milk Oligosaccharides (HMO) Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Inbiose Recent Developments
11.3 Glycom
11.3.1 Glycom Corporation Information
11.3.2 Glycom Overview
11.3.3 Glycom Human Milk Oligosaccharides (HMO) Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Glycom Human Milk Oligosaccharides (HMO) Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Glycom Recent Developments
11.4 Chr. Hansen (Jennewein)
11.4.1 Chr. Hansen (Jennewein) Corporation Information
11.4.2 Chr. Hansen (Jennewein) Overview
11.4.3 Chr. Hansen (Jennewein) Human Milk Oligosaccharides (HMO) Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Chr. Hansen (Jennewein) Human Milk Oligosaccharides (HMO) Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Chr. Hansen (Jennewein) Recent Developments
11.5 Elicityl SA
11.5.1 Elicityl SA Corporation Information
11.5.2 Elicityl SA Overview
11.5.3 Elicityl SA Human Milk Oligosaccharides (HMO) Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Elicityl SA Human Milk Oligosaccharides (HMO) Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Elicityl SA Recent Developments
11.6 ZuChem
11.6.1 ZuChem Corporation Information
11.6.2 ZuChem Overview
11.6.3 ZuChem Human Milk Oligosaccharides (HMO) Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 ZuChem Human Milk Oligosaccharides (HMO) Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 ZuChem Recent Developments
11.7 Dextra Laboratories
11.7.1 Dextra Laboratories Corporation Information
11.7.2 Dextra Laboratories Overview
11.7.3 Dextra Laboratories Human Milk Oligosaccharides (HMO) Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Dextra Laboratories Human Milk Oligosaccharides (HMO) Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Dextra Laboratories Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Human Milk Oligosaccharides (HMO) Industry Chain Analysis
12.2 Human Milk Oligosaccharides (HMO) Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Human Milk Oligosaccharides (HMO) Production Mode & Process
12.4 Human Milk Oligosaccharides (HMO) Sales and Marketing
12.4.1 Human Milk Oligosaccharides (HMO) Sales Channels
12.4.2 Human Milk Oligosaccharides (HMO) Distributors
12.5 Human Milk Oligosaccharides (HMO) Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Human Milk Oligosaccharides (HMO) Industry Trends
13.2 Human Milk Oligosaccharides (HMO) Market Drivers
13.3 Human Milk Oligosaccharides (HMO) Market Challenges
13.4 Human Milk Oligosaccharides (HMO) Market Restraints
14 Key Findings in The Global Human Milk Oligosaccharides (HMO) Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer